Concepedia
Statistics
Publications
12
Citations
924
H-Index
11
Active since
1976
Affiliations
Duke Medical Center(Current)
University of Utah
Providence Saint Joseph Medical Center
Seagen (United States)
Willamette Valley Cancer Institute and Research Center
Gregg A. Olsen is an author at Duke Medical Center specializing in medicine, pharmacology, and chemotherapy.
Publications per year
1976–2017
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
W. P. Peters, E.J. Shpall, R B Jones et al. · Journal of Clinical Oncology · 1988 · 384 citations
Medicine, Oncology, Pharmacology +13
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older
Andres Forero‐Torres, Beata Holkova, Jerome H. Goldschmidt et al. · Blood · 2015 · 142 citations · Full text
Medicine, Oncology, Pharmacotherapy +11
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Jonathan W. Friedberg, Andres Forero‐Torres, Rodolfo Bordoni et al. · Blood · 2017 · 90 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +3
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.
W. P. Peters, W. David Henner, L B Grochow et al. · PubMed · 1987 · 73 citations
Fine-needle aspiration biopsy of the mediastinum
James Linder, Gregg A. Olsen, William W. Johnston · The American Journal of Medicine · 1986 · 45 citations
Medicine, Pathology, Diagnostic Pathology +6
1–5 of 12